Novel markers in the acute coronary syndrome: BNP, IL-6, PAPP-A

American Journal of Critical Care

Volumn 11, Issue 2, 2002, Pages 168-172

  Futterman, Laurie G ^a   Lemberg, Louis ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ACUTE DISEASE; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; SYNDROME;

ACUTE DISEASE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CORONARY DISEASE; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; SYNDROME;

EID: 0036515331     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2002.11.2.168     Document Type: Article

References (18)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126.
2. Bayes-Genis A, Mateo J, Santalo M, et al. D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain. Am Heart J. 2000;140:379-384.
3. Puelo PR, Meyer D, Wathen C, et al. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med. 1994;331:561-566.
4. Vorchheimer DA, Fuster V. Inflammatory markers in coronary artery disease: let prevention douse the flames. JAMA. 2001;286:2154-2155.
5. Bayes-Genis A, Conover CA, Overgaard MT, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med. 2001;345:1022-1029.
6. Newby LK. Cardiac marker testing: where should we focus? Am Heart J. 2000;140:351-352.
7. Rabbini L. Acute coronary syndromes: beyond myocyte necrosis. N Engl J Med. 2001;345:1057-1058.
8. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014-1021.
9. Troughton RW, Framptom CM, Yandle TG, Espiner EA, Nicholis MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;335:1126-1130.
10. Lindmark E, Diderhom E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease. JAMA. 2001;286:2107-2113.
11. Harris TB, Ferricco L, Tracy RP, et al. Associations of elevated interleukin-6 and c-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
12. Zhang R, Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 2001;286:2136-2142.
13. Futterman LG, Lemberg L. SGOT, LDH, CPK, CPKMB, MB1MB2, cTnT, cTnC, cTnI. Am J Crit Care. 1997;6:333-339.
14. Futterman LG, Lemberg L. Inflammation in plaque rupture: an active participant or an invited guest? Am J Crit Care. 1998;7:153-161.
15. Hammm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 1997;337;1648-1653.
16. Ridker PM, Rifai N, Clearfield M, et al. C-reactive protein: a modifiable coronary risk factor. N Engl J Med. 2001;344:1959-1965.
17. Stanek B, Frey B, Hulsmann M, et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 2001;38:436-442.
18. Uusimaa P, Ruskoaho H, Vuolteenaho O, et al. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction. Int J Cardiol. 1999;69:5-15.